Mahroum, Naim
Watad, Abdulla
Tiosano, Shmuel
Hejly, Ashraf
Mahagna, Hussein
Waknin, Roy
Comaneshter, Doron
Cohen, Arnon D.
Amital, Howard
Article History
Received: 17 January 2019
Accepted: 21 January 2019
First Online: 8 February 2019
Compliance with ethical standards
: The study was approved by the ethical committee of CHS, located at the Soroka Medical Center, Beer-Sheva, Israel.
: Naim Mahroum- no conflict of interests.Abdulla Watad - no conflict of interests.Shmuel Tiosano - no conflict of interests.Ashraf Hejly - no conflict of interests.Hussein Mahagna - no conflict of interests.Roy Waknin - no conflict of interests.Doron Comaneshter - no conflict of interests.Arnon Cohen received research grants from Janssen, Novartis, AbbVie, and Sanofi. Other relationships: In the last 3 years, Prof. Arnon Cohen served as a consultant, advisor, or speaker to AbbVie; Amgen; Boehringer Ingelheim; Dexcel pharma; Janssen; Kamedis; Lilly; Neopharm; Novartis; Perrigo; Pfizer, Rafa, Sanofi, Sirbal; Taro.Howard Amital- received research grants from Janssen, Novartis, AbbVie and Pfizer. Other relationships: In the last 3 years Howard Amital served as a consultant, advisor or speaker to AbbVie; Boehringer Ingelheim; Janssen; Neopharm; Novartis; Perrigo; Pfizer, Rafa, Sanofi, Sanofi, Taro, Roche.